Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download TAG Mail 5 October 2016
Document related concepts
Transcript
TAG Mail 5 October 2016 The purpose of TAG Mail is to assist TAG members identify and share relevant information for their professional practice. Members are encouraged to routinely forward TAG Mail to others who they believe would benefit from this information such as colleagues in the same hospital department if they are not already receiving TAG Mail. TAG ACTIVITIES - Sasha Bennett will be away until the 13 October. For urgent enquiries to NSW TAG, please contact Christa Lynch [email protected] while Sasha is away. - Letter to MJA ‘Using opioids in general practice for chronic non-cancer pain: an overview of current evidence’ https://www.mja.com.au/journal/2016/205/7/using-opioids-general-practice-chronic-non-cancerpain-overview-current-evidenc-0 - Email discussion: Introduction of 'ENFit' syringes. Closes 13 October 2016 - Email discussion: Sterile Hydrogen Peroxide Plastic Steritubes 3% 30mL Supply Disruption. Closes 7 October 2016. TAG WEBSITE **Practical Guidance The following document is now available on the website: - Opioid Skin Patches are High Risk Medicines http://www.ciap.health.nsw.gov.au/nswtag/reviews/practical-guidance.html **Discussion Paper The following document is now available on the website: - Patient self-funding offers to access medicines: Drug and Therapeutic Committee considerations http://www.ciap.health.nsw.gov.au/nswtag/reviews/discussion-papers.html **CIAP - CIAP has disabled the following forms on the NSW TAG website: http://www.ciap.health.nsw.gov.au/nswtag/about/contact.html http://www.ciap.health.nsw.gov.au/nswtag/about/how-to-apply.html Please contact NSW TAG via email [email protected] or by calling 02 8382 2852. CONSULTATIONS **TGA - Regulation of autologous cell and tissue products and proposed consequential changes to the classification of biological. Closes 6 October 2016 http://www.tga.gov.au/consultation/consultation-regulation-autologous-cell-and-tissue-productsand-proposed-consequential-changes-classification-biologicals - Proposed amendments to the poisons standard: Invitation to comment (up-scheduling of pentobarbital; exemptions for hemp seed oil from Schedules 8 and 9; Appendix K entry for guanfacine hydrochloride; new Schedule 4 entry for tianeptine). Closes 20 October 2016 http://www.tga.gov.au/consultation-invitation/consultation-proposed-amendments-poisonsstandard-joint-accs-and-acms-meeting-november-2016 - Consultations on adoption of European Union guidelines in Australia. Closes 9 November 2016 http://www.tga.gov.au/consultation/consultations-adoption-european-union-guidelines-australia REPORTS AND PUBLICATIONS – AUSTRALIA **AIHW - Incidence of end-stage kidney disease in Australia 1997-2013 http://www.aihw.gov.au/publication-detail/?id=60129557152 - Tobacco indicators: measuring midpoint progress-reporting under the National Tobacco Strategy 2012-2018 http://www.aihw.gov.au/publication-detail/?id=60129557116 **TGA - Medicine shortages change in status: Metformin extended release tablets (update 3) http://www.tga.gov.au/alert/metformin-extended-release-tablets - The Poisons Standard October 2016 (SUSMP Number 14) http://www.tga.gov.au/publication/poisons-standard-susmp - Prescription medicines: Extension of indications Brentuximab vedotin (rch) (AdcetrisTM) now also indicated for the treatment of adult patients with CD30+ Hodgkin lymphoma at higher risk of relapse or progression following ASCT http://www.tga.gov.au/prescription-medicines-new-or-extended-uses-registered-medicines - Prescription medicines: Registration of new chemical entities Elotuzumab (EmplicitiTM) for use in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy Daclizumab (ZinbrytaTM) for the treatment of relapsing forms of multiple sclerosis to delay the progression of physical disability and to reduce the frequency of relapse Albutrepenonacog alpha (IdelvionTM) for use in all patients with Haemophilia B http://www.tga.gov.au/prescription-medicines-registration-new-chemical-entities-austalia REPORTS AND PUBLICATIONS – INTERNATIONAL **FDA - Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor blood glucose and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm522974.htm **Healthy Canadians - Health product InfoWatch – September 2016 http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2016-09-eng.php **NIHR Signals - Vomiting is the most common adverse effect among children and young people sedated for emergency procedures https://discover.dc.nihr.ac.uk/portal/article/4000427/vomiting-is-the-most-common-adverse-effectamong-children-and-young-people-sedated-for-emergency-procedures - Rhythm control drugs after catheter ablation for atrial fibrillation give short-term but not long term benefits https://discover.dc.nihr.ac.uk/portal/article/4000431/rhythm-control-drugs-after-catheter-ablationfor-atrial-fibrillation-give-short-term-but-not-long-term-benefits - Epidural anaesthesia helps return of bowel function after abdominal surgery https://discover.dc.nihr.ac.uk/portal/article/4000432/epidural-anaesthesia-helps-return-of-bowelfunction-after-abdominal-surgery *SIGN UK - British guideline on the management of asthma http://www.sign.ac.uk/guidelines/fulltext/153/index.html MEDICATION SAFETY **SABS - Avoiding thrombophlebitis with intravenous amiodarone http://internal.health.nsw.gov.au/quality/sabs/pdf/2016-sn-009.PDF **FDA - FDA warns against the use of homeopathic teething tablets and gels http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm523468.htm **Healthy Canadians - Health Product InfoWatch – September 2016 Monthly recap of product safety information: riociguat in pulmonary hypertension; etanercept during pregnancy; antidepressants and angle-closure glaucoma; atypical antipsychotics and sleep apnoea http://www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/hpiw-ivps_2016-09-eng.php OTHER NEWS **Enabling pharmacists to improve the care of people living with a disability in NSW - The University of Sydney is conducting research into the impact of a pilot educational initiative regarding disability for pharmacists The study aims to up-skill pharmacists in the pharmacotherapeutics of disabling conditions, improve pharmacists’ skills in communication with people with disabilities, and raise pharmacists’ awareness of disability. Participation involves attendance at a half-day workshop, completion of a self-study manual, and selfreflection exercises. The workshop will be held from 2-5 pm on Sunday 30th October 2016 at the University of Sydney. There is no cost to participate and the activities can be self-reported for CPD points. Places are filling up so if you would like to participate or find out more please call Sharon Davis on 0411817299, or email [email protected]. PAPERS OF INTEREST **Australian Prescriber - New drug: Idarucizumab for dabigatran reversal https://www.nps.org.au/australianprescriber/articles/idarucizumab?utm_medium=email&utm_source=16-10-05&utm_campaign=ausprescriber - New drug: Evolocumab for hypercholesterolaemia https://www.nps.org.au/australianprescriber/articles/evolocumab?utm_medium=email&utm_source=16-10-05&utm_campaign=ausprescriber **British Journal of Clinical Pharmacology - The impact of serious adverse drug reactions: a population-based study of a decade of hospital admissions in New South Wales, Australia http://onlinelibrary.wiley.com/doi/10.1111/bcp.13124/abstract - Do pharmacist-led medication reviews in hospitals help reduce hospital readmissions? A systematic review and meta-analysis http://onlinelibrary.wiley.com/doi/10.1111/bcp.13085/abstract - Does tablet formulation alone improve adherence and persistence: a comparison of ezetimibe fixed dose combination versus ezetimibe separate pill combination? http://onlinelibrary.wiley.com/doi/10.1111/bcp.13088/abstract **The BMJ - Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial http://www.bmj.com/content/354/bmj.i4935 - Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study http://www.bmj.com/content/354/bmj.i4857 **Canadian Pharmacists Journal - A randomized trial of a community-based approach to dyslipidemia management: Pharmacist prescribing to achieve cholesterol targets (RxACT Study) http://cph.sagepub.com/content/149/5/283.full **Cochrane Library - Antibiotic treatment for the sexual partners of women with bacterial vaginosis http://www.cochrane.org/CD011701/STI_antibiotic-treatment-sexual-partners-women-bacterialvaginosis - Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003715.pub3/abstract;jsessionid=446945E4 1E058DCD54FD72C9DC54DDBB.f03t04 - Medical interventions for the prevention of platinum-induced hearing loss in children with cancer http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009219.pub4/abstract - Pregabalin for pain in fibromyalgia in adults http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011790.pub2/abstract - Vitamin A supplementation for infants one to six months of age for preventing death and illnesses http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009219.pub4/abstract **European Heart Journal - 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines http://eurheartj.oxfordjournals.org/content/37/36/2768 **Health Expectations - Shared decision making for psychiatric medication management: beyond the micro-social http://onlinelibrary.wiley.com/doi/10.1111/hex.12392/full **International Journal for Quality in Health Care - Usefulness of quality indicators for antibiotic use: case study for the Netherlands http://intqhc.oxfordjournals.org/content/early/2016/09/23/intqhc.mzw117 **JAMA - Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial http://jama.jamanetwork.com/article.aspx?articleid=2565176 **JAMA Internal Medicine - Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated With Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation http://archinte.jamanetwork.com/article.aspx?articleid=2560376 **JAMIA - Computerized prescriber order entry–related patient safety reports: analysis of 2522 medication errors http://jamia.oxfordjournals.org/content/early/2016/09/27/jamia.ocw125 **NEJM - Adjunctive Azithromycin Prophylaxis for Cesarean Delivery http://www.nejm.org/doi/full/10.1056/NEJMoa1602044 - Effectiveness of Fluticasone Furoate–Vilanterol for COPD in Clinical Practice http://www.nejm.org/doi/full/10.1056/NEJMoa1608033 - Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease http://www.nejm.org/doi/full/10.1056/NEJMoa1607991?query=TOC **National Institute for Health Research Journal - Financial incentives to improve adherence to antipsychotic maintenance medication in nonadherent patients: a cluster randomised controlled trial http://www.journalslibrary.nihr.ac.uk/hta/volume-20/issue-70#abstract *The Lancet: Respiratory Medicine - Development and internal validation of a clinical rule to improve antibiotic use in children presenting to primary care with acute respiratory tract infection and cough: a prognostic cohort study http://www.thelancet.com/journals/lanres/article/PIIS2213-2600(16)30223-5/fulltext UPCOMING EVENTS (new additions in bold) **Health Data Analytics “Data Informing Health 2016” 11-12th October 2016, Mercure Hotel, Brisbane http://www.hisa.org.au/healthdataanalytics/program-and-speakers/ **Change Champions & Associates Workshop “A Healthy Hospital is a Happier, Safer and More Productive Place for Care” 12–13th October 2016, Melbourne Cricket Ground, Richmond, Victoria http://www.changechampions.com.au/seminar/a-healthy-hospital-is-a-happy-safer-and-moreproductive-place-for-care_653 **Asthma Australia ‘Connecting Asthma Care’ Asthma Symposia Series 13 – 26 October 2016, Sydney asthmaaustralia.org.au/symposium **Health Quality and Safety Commission New Zealand: ‘Quality Improvement scientific symposium’ 18 October 2016, 9am – 4pm Novotel Auckland Airport, NZ. http://www.hqsc.govt.nz/assets/General-NEMR-files-images-/scientific-symposium-STD-Apr-2016.pdf **Australian Disease Management Association 12th Annual National Conference “Person Centred Healthcare: Achievements & Challenges”, 20-22 October 2016, Melbourne http://www.adma.org.au/images/ConferenceFlyer_2016.pdf **Integrated Emergency Care for Older Persons Summit 26-28 October 2016, Melbourne Convention & Exhibition Centre http://www.cvent.com/e.aspx?1T **Secondary Prevention in Cardiology Conference 2016 ‘Ideas, Innovation and Inspiration from the Coalface’, 28 October 2016, The Royal Brisbane and Women’s Hospital, QLD (Videoconferencing available) http://www.acra.net.au/event/qcra-heart-foundation-conference-2016/ **Therapeutics Initiative ‘Bringing Best Evidence to Clinicians: Combining Evidence and Clinical Pharmacology to Improve Drug Therapy’, 29 October 2016 Surrey Memorial Hospital, 13750 96 Ave, Surrey BC, UK http://www.ti.ubc.ca/2016/04/23/bringing-best-evidence-clinicians-combining-evidence-clinicalpharmacology-improve-drug-therapy-2/ **Australian Association for Quality in Healthcare ‘Using Data to Drive Change’ Friday 11th November 2016, Novotel Hotel Parramatta https://www.aaqhc.org.au/upcoming-events/nsw-education-day-novotel-parramatta/ **American Medical Informatics Association (AMIA) “Annual Symposium 2016” 12-16th November 2016, Chicago, USA https://www.amia.org/amia2016/registration#.V8HzwXLi-5I **SHPA Medicines Management 2016 Conference 16-19 November 2016, Perth Convention and Exhibition Centre, WA http://mm2016shpa.com/ **4th World Congress on Integrated Care “Investing in our Future: Improving the Health of People and Communities (WCIC4)” 23-25 November 2016, Wellington New Zealand http://integratedcarefoundation.org/events/wcic4-4th-world-congress-on-integrated-carewellington-new-zealand **ASCEPT-MPGPCR 2016 Meeting, 27-30 November 2016, Melbourne Convention Centre Abstracts close: 26 September 2016 http://www.asceptasm.com **ISMP Medication Safety Intensive, 2-3 December 2016, Las Vegas http://www.ismp.org/educational/MSI/ ** APSA 2016 Annual Conference, 2-5 December 2016, University of Sydney https://expertevents.eventsair.com/QuickEventWebsitePortal/apsa2016/website **The 16th APCCMI (Asia Pacific Congress of Clinical Microbiology & Infection) 30 November - 3 December, 2016, Melbourne. For more information on the meeting including abstract submission and registration please visit: www.apccmi2016.org **2nd Digital Hospital of the Future, ANZ 2016 ‘Improving Patient Care Delivery and Monitoring with Digital Technology Innovations and Transformation’ 7th-9th December 2016, InterContinental Sydney Australia http://claridenglobal.com/conference/digitalhospital2016/?utm_campaign=L6285_Digital%20Hospita l_AU_EDM%202_Buy&utm_medium=email&utm_source=Eloqua **Australian Society for Antimicrobials Antimicrobials 2017 and StaphPath 2017 Adelaide. 23 - 25 February and 25 - 26 February 2017 Abstract Submission Deadline: Friday, 9 December 2016 www.antimicrobials2017.com **ISMP CHA Medication Safety Intensive, Sydney, March 9-10 2017. Early bird ends 31 October 2016 https://children.wcha.asn.au/ismp_medsafety **CADTH Symposium, April 23, 2017 - April 25, 2017: Shaw Centre, Ottawa, Ontario https://www.cadth.ca/events/2017-cadth-symposium **2017 NSW Patient Experience Symposium, 1st-2nd May 2017 Bay 4, Australian Technology Park Locomotive St, Eveleigh NSW (Abstract Submissions close COB Friday 21st October 2016) http://www.alignmentevents.com.au/sh_events/2017-nsw-patient-experience-symposium-call-forabstracts/#1473648903182-6aa8fa3c-649b You are receiving this email because you or a workplace colleague has requested TAG Mail. NSW TAG analyses uptake of TAG Mail (email openings and clicks on specific contents) in order to optimise the TAG Mail service for our members and colleagues. By requesting TAG Mail, you are also agreeing to have your data (email address, country of abode) captured. All information obtained is used in accordance with NSW Health Privacy Policy. Please contact NSW TAG at [email protected] if you have any questions regarding this.
